Analysis of 14 candidate genes for diabetic nephropathy on chromosome 3q in european populations: Strongest evidence for association with a variant in the promoter region of the adiponectin gene

Diabetes

Volumn 55, Issue 11, 2006, Pages 3166-3174

  Vionnet, Nathalie ^a,c   Tregouët, David ^a   Kazeem, Gbenga ^b   Gut, Ivo ^c   Groop, Per Henrik ^d,e   Tarnow, Lise ^f   Parving, Hans Henrik ^f   Hadjadj, Samy ^g   Forsblom, Carol ^d,e   Farrall, Martin ^b   Gauguier, Dominique ^b   Cox, Roger ^h   Matsuda, Fumihiko ^c   Heath, Simon ^c   Thévard, Alexandre ^a   Rousseau, Rachel ^a   Cambien, François ^a   Marre, Michel ^a,i   Lathrop, Mark ^c  

^a INSERM   (France)

^b UNIVERSITY OF OXFORD   (United Kingdom)

^c CENTRE NATIONAL DE GÉNOTYPAGE   (France)

^d HELSINKI UNIVERSITY CENTRAL HOSPITAL   (Finland)

^e FOLKHÄLSAN INSTITUTE OF GENETICS   (Finland)

^f STENO DIABETES CENTER   (Denmark)

^g POITIERS UNIVERSITY HOSPITAL   (France)

^h Mammalian Research Council   (United Kingdom)

ⁱ BICHAT HOSPITAL   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ADIPONECTIN; ANGIOTENSIN 2 RECEPTOR; APOLIPOPROTEIN D; CYTOKINE; ENDOTHELIN CONVERTING ENZYME; ENDOTHELIN CONVERTING ENZYME 2; ENOYL COENZYME A HYDRATASE; GLUCOSE TRANSPORTER 2; HISTIDINE DERIVATIVE; HISTIDINE RICH GLYCOPROTEIN; INTERLEUKIN 12P35; KININOGEN; PENTRAXIN 3; PHOSPHOPROTEIN PHOSPHATASE 1; PROTEIN PHOSPHATASE 1 REGULATORY SUBUNIT 2; SOMATOSTATIN; THROMBOPOIETIN; TUMOR NECROSIS FACTOR SUPERFAMILY MEMBER 10;

ADULT; ALLELE; ARTICLE; CARDIOVASCULAR DISEASE; CHROMOSOME 3Q; CHROMOSOME ANALYSIS; CONTROLLED STUDY; DENMARK; DIABETIC NEPHROPATHY; DISEASE ASSOCIATION; DISEASE COURSE; FINLAND; FRANCE; GENE FREQUENCY; GENE IDENTIFICATION; GENE LINKAGE DISEQUILIBRIUM; GENE SEQUENCE; GENETIC ANALYSIS; GENETIC LINKAGE; GENETIC VARIABILITY; GENOTYPE; HAPLOTYPE; HUMAN; INSULIN DEPENDENT DIABETES MELLITUS; MAJOR CLINICAL STUDY; PHENOTYPE; PRIORITY JOURNAL; PROMOTER REGION; RISK ASSESSMENT; RISK REDUCTION; SINGLE NUCLEOTIDE POLYMORPHISM;

EID: 33845515326     PISSN: 00121797     EISSN: 00121797     Source Type: Journal    
DOI: 10.2337/db06-0271     Document Type: Article

References (50)

1. Andersen AR, Christiansen JS, Andersen JK, Kreiner S, Deckert T: Diabetic nephropathy in type 1 (insulin-dependent) diabetes: an epidemiological study. Diabetologia 25:496-501, 1983
2. Borch-Johnsen K, Kreiner S: Proteinuria value as predictor of cardiovascular mortality in insulin dependent diabetes mellitus. BMJ 294:1651-1654, 1987
3. Seaquist ER, Goetz FC, Rich S, Barbosa J: Familial clustering of diabetic kidney disease: evidence for genetic susceptibility to diabetic nephropathy. N Engl J Med 320:1161-1165, 1989
4. Quinn M, Angelico MC, Warram JH, Krolewski AS: Familial factors determine the development of diabetic nephropathy in patients with IDDM. Diabetologia 39:940-945, 1996
5. Earle K, Walker J, Hill C, Viberti GC: Familial clustering of cardiovascular disease in patients with insulin-dependent diabetes and nephropathy. N Engl J Med 326:673-677, 1992
6. The Diabetes Control and Complications Trial Research Group: Clustering of long-term complications in families with diabetes in the diabetes control and complications trial. Diabetes 46:1829-1839, 1997
7. Faronato PP, Maioli M, Tonolo G, Brocco E, Noventa F, Piarulli F, Abaterusso C, Modena F, de Bigontina G, Velussi M, Inchiostro S, Santeusanio F, Bueti A, Nosadini R, the Italian NIDDM Nephropathy Study Group: Clustering of albumin excretion rate abnormalities in Caucasian patients with NIDDM. Diabetologia 40:816-823, 1997
8. Lindsay RS, Little J, Jaap AJ, Padfield PL, Walker JD, Hardy KJ: Diabetic nephropathy is associated with an increased familial risk of stroke. Diabetes Care 22:422-425, 1999
9. Viberti GC, Keen H, Wiseman MJ: Raised arterial pressure in parents of proteinuric insulin-dependent diabetics. Br Med J 295:515-517, 1987
10. Krolewski AS, Canessa H, Warram JH, Laffel L, Christlieb AR, Knowler WC, Rand LI: Predisposition to hypertension and susceptibility to renal disease in insulin-dependent diabetes mellitus. N Engl J Med 318:140-145, 1988
11. Hadjadj S, Pean F, Gallois Y, Passa P, Aubert R, Weekers L, Rigalleau V, Bauduceau B, Bekherraz A, Roussel R, Dussol B, Rodier M, Marechaud R, Lefebvre PJ, Marre M: Different patterns of insulin resistance in relatives of type 1 diabetic patients with retinopathy or nephropathy: the Genesis France-Belgium Study. Diabetes Care 27:2661-2668, 2004
12. Moczulski DK, Rogus JJ, Antonellis A, Warram JH, Krolewski AS: Major susceptibility locus for nephropathy in type 1 diabetes on chromosome 3q: results of novel discordant sib-pair analysis. Diabetes 47:1164-1169, 1998
13. Imperatore G, Hanson RL, Pettitt DJ, Kobes S, Bennett PH, Knowler WC, the Pima Diabetes Genes Group: Sib-pair linkage analysis for susceptibility genes for microvascular complications among Pima Indians with type 2 diabetes. Diabetes 47:821-830, 1998
14. Bowden DW, Colicigno CJ, Langefeld CD, Sale MM, Williams A, Anderson PJ, Rich SS, Freedman BI: A genome scan for diabetic nephropathy in African Americans. Kidney Int 66:1517-1526, 2004
15. Kissebah AH, Sonnenberg GE, Myklebust J, Goldstein M, Broman K, James RG, Marks JA, Krakower GR, Jacob HJ, Weber J, Martin L, Blangero J, Comuzzie AG: Quantitative trait loci on chromosomes 3 and 17 influence phenotypes of the metabolic syndrome. Proc Natl Acad Sci U S A 97:14478-14483, 2000
16. Vionnet N, Hani El-H, Dupont S, Gallina S, Francke S, Dotte S, De Matos F, Durand E, Lepretre F, Lecoeur C, Gallina P, Zekiri L, Dina C, Froguel P: Genomewide search for type 2 diabetes-susceptibility genes in French whites: evidence for a novel susceptibility locus for early onset diabetes on chromosome 3q27-qter and independent replication of a type 2 diabetes locus on chromosome 1q21-q24. Am J Hum Genet 67:1470-1480, 2000
17. Wu X, Cooper RS, Borecki I, Hanis C, Bray M, Lewis CE, Zhu X, Kan D, Luke A, Curb D: A combined analysis of genomewide linkage scans for body mass index from the National Heart, Lung, and Blood Institute Family Blood Pressure Program. Am J Hum Genet 70:1247-1256, 2002
18. Francke S, Manraj M, Lacquemant C, Lecoeur C, Lepretre F, Passa P, Hebe A, Corset L, Yan SL, Lahmidi S, Jankee S, Gunness TK, Ramjuttun US, Balgobin V, Dina C, Froguel P: A genome-wide scan for coronary heart disease suggests in Indo-Mauritians a susceptibility locus on chromosome 16p13 and replicates linkage with the metabolic syndrome on 3q27. Hum Mol Genet 10:2751-2765, 2001
19. Chiodini BD, Lewis CM: Meta-analysis of 4 coronary heart disease genome-wide linkage studies confirms a susceptibility locus on chromosome 3q. Arterioscler Thromb Vasc Biol 23:1863-1868, 2003
20. DeWan AT, Arnett DK, Atwood LD, Province MA, Lewis CE, Hunt SC, Eckfeldt J: A genome scan for renal function among hypertensives: the HyperGEN study. Am J Hum Genet 68:136-144, 2001
21. Takahashi M, Matsuda F, Margetic N, Lathrop M: Automated identification of single nucleotide polymorphisms from sequencing data. J Bioinform Comput Biol 1:253-265, 2003
22. Dempster AP, Laird NM, Rubin DB: Maximum likelihood from incomplete data via the EM algotrithm. J Royal Stat Soc B 39:1-38, 1977
23. Devlin B, Roeder K: Genomic control for association studies. Biometrics 55:997-1004, 1999
24. Sauer S, Lechner D, Berlin K, Plançon C, Heuermann A, Lehrach H, Gut IG: Full flexibility genotyping of single nucleotide polymorphisms by the GOOD assay. Nucleic Acids Res 28:e100, 2000
25. Tregouet DA, Escolano S, Tiret L, Mallet A, Golmard JL: A new algorithm for haplotype-based association analysis: the Stochastic-EM algorithm. Ann Intern Med 68:165-177, 2004
26. Paul SR, Donner A: A comparison of tests of homogeneity of odds ratio in k 2x2 tables. Stat Med 8:1455-1468, 1989
27. Fisher RA: Statistical Methods for Research Workers, 13th ed. London, Oliver & Boyd, 1925
28. Clayton D: A generalization of the transmission/disequilibrium test for uncertain-haplotype transmission. Am J Hum Genet 65:1170-1177, 1999
29. Spielman RS, McGinnis RE, Ewens WJ: Transmission test for linkage disequilibrium: the insulin gene region and insulin-dependent diabetes mellitus (IDDM). Am J Hum Genet 52:506-516, 1993
30. Nagelkerke NJD, Hoebee B, Teunis P, Kimman TG: Combining the transmission disequilibrium test and case-control methodology using generalized logistic regression. Eur J Hum Genet 12:964-970, 2004
31. Kazeem GR, Farrall M: Integrating case-control and TDT studies. Ann Hum Genet 69:329-335, 2005
32. Nyholt DR: A simple correction for multiple testing for single-nucleotide polymorphisms in linkage disequilibrium with each other. Am J Hum Genet 74:765-769, 2004
33. Crawford DC, Carlson CS, Rieder MJ, Carrington DP, Yi Q, Smith JD, Eberle MA, Kruglyak L, Nickerson DA: Haplotype diversity across 100 candidate genes for inflammation, lipid metabolism, and blood pressure regulation in two populations. Am J Hum Genet 74:610-622, 2004
34. Zhang W, Collins A, Morton NE: Does haplotype diversity predict power for association mapping of disease susceptibility? Hum Genet 115:157-164, 2004
35. Akey J, Jin L, Xiong M: Haplotypes vs single marker linkage disequilibrium tests: what do we gain? Eur J Hum Genet 9:291-300, 2001
36. Zhu X, Fejerman L, Luke A, Adeyemo A, Cooper RS: Haplotypes produced from rare variants in the promoter and coding regions of angiotensinogen contribute to variation in angiotensinogen levels. Hum Mol Genet 14:639-643, 2005
37. Vasseur F, Helbecque N, Lobbens S, Vasseur-Delannoy V, Dina C, Clement K, Boutin P, Kadowaki T, Scherer PE, Froguel P: Hypoadiponectinaemia and high risk of type 2 diabetes are associated with adiponectin-encoding (ADIPOQ) gene promoter variants in morbid obesity: evidence for a role of ADIPOQ in diabesity. Diabetologia 48:892-899, 2005
38. Vasseur F, Helbecque N, Dina C, Lobbens S, Delannoy V, Gaget S, Boutin P, Vaxillaire M, Lepretre F, Dupont S, Hara K, Clement K, Bihain B, Kadowaki T, Froguel P: Single-nucleotide polymorphism haplotypes in the both proximal promoter and exon 3 of the ADIPOQ gene modulate adipocyte-secreted adiponectin hormone levels and contribute to the genetic risk for type 2 diabetes in French Caucasians. Hum Mol Genet 11:2607-2614, 2002
39. Fasshauer M, Paschke R, Stumvoll M: Adiponectin, obesity, and cardiovascular disease. Biochimie 86:779-784, 2004
40. Yang WS, Chuang LM: Human genetics of adiponectin in the metabolic syndrome. J Mol Med 31:1-10, 2005
41. Frystyk J, Tarnow L, Krarup Hansen T, Parving HH, Flyvbjerg A: Increased serum adiponectin levels in type 1 diabetic patients with microvascular complications. Diabetologia 48:1911-1918, 2005
42. Saraheimo M, Forsblom C, Fagerudd J, Teppo AM, Pettersson-Fernholm K, Frystyk J, Flyvbjerg A, Groop PH: Serum adiponectin is increased in type 1 diabetic patients with nephropathy. Diabetes Care 28:1410-1414, 2005
43. Hadjadj S, Aubert R, Fumeron F, Pean F, Tichet J, Roussel R, Marre M, the SURGENE Study Group, the DESIR Study Group: Increased plasma adiponectin concentrations are associated with microangiopathy in type 1 diabetic subjects. Diabetologia 48:1088-1092, 2005
44. Kita A, Yamasaki H, Kuwahara H, Moriuchi A, Fukushima K, Kobayashi M, Fukushima T, Takahashi R, Abiru N, Uotani S, Kawasaki E, Eguchi K: Identification of the promoter region required for human adiponectin gene transcription: association with CCAAT/enhancer binding protein-[β] and tumor necrosis factor-[α]. Biochem Biophys Res Commun 331:484-490, 2005
45. Park SK, Oh SY, Lee MY, Yoon S, Kim KS, Kim JW: CCAAT/enhancer binding protein and nuclear factor-Y regulate adiponectin gene expression in adipose tissue. Diabetes 53:2757-2766, 2004
46. Qiao L, Maclean PS, Schaack J, Orlicky DJ, Darimont C, Pagliassotti M, Friedman JE, Shao J: C/EBP{α} regulates human adiponectin gene transcription through an intronic enhancer. Diabetes 54:1744-1754, 2005
47. Antonellis A, Rogus JJ, Canani LH, Makita Y, Pezzolesi MG, Nam M, Ng D, Moczulski D, Warram JH, Krolewski AS: A method for developing highdensity SNP maps and its application at the type 1 angiotensin II receptor (AGTR1) locus. Genomics 79:326-332, 2002
48. Tarnow L, Cambien F, Rossing P, Nielsen FS, Hansen BV, Ricard S, Poirer O, Parving HH: Angiotensin-II type 1 receptor gene polymorphism and diabetic microangiopathy. Nephrol Dial Transplant 11:1019-1023, 1996
49. Marre M, Jeunemaitre X, Gallois Y, Rodier M, Chatellier G, Sert C, Dusselier L, Kahal Z, Chaillous L, Halimi S, Muller A, Sackmann H, Bauduceau B, Bled F, Passa P, Alhenc-Gelas F, the Genetique de la Nephropathie Diabetique (GENEDIAB) Study Group: Contribution of genetic polymorphism in the renin-angiotensin system to the development of renal complications in insulin-dependent diabetes. J Clin Invest 99: 1585-1595, 1997
50. Chistiakov DA, Savost'anov KV, Shestakova MV, Chugunova LA, Samkhalova MSh, Dedov II, Nosikov VV: Confirmation of a susceptibility locus for diabetic nephropathy on chromosome 3q23-q24 by association study in Russian type 1 diabetic patients. Diabetes Res Clin Pract 66:79-86, 2004